2022
DOI: 10.1016/j.phrs.2021.106045
|View full text |Cite
|
Sign up to set email alerts
|

The dualistic role of the purinergic P2Y12-receptor in an in vivo model of Parkinson's disease: Signalling pathway and novel therapeutic targets

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 15 publications
(5 citation statements)
references
References 77 publications
(96 reference statements)
0
4
0
Order By: Relevance
“…Considering that P2Y receptors are associated with age‐related functional changes in other tissues (Erb et al., 2015 ; Gao et al., 2019 ; Iring et al., 2022 ; Reichenbach & Bringmann, 2016 ; Wallace et al., 2006 ), we hypothesised that they could also play a role in the altered functions of the aged cochlea. In this study, we used different mouse lines displaying varying degrees of progressive hearing loss to identify possible changes in the distribution and functional properties of P2Y receptors in the supporting cells of the ageing mouse.…”
Section: Introductionmentioning
confidence: 99%
“…Considering that P2Y receptors are associated with age‐related functional changes in other tissues (Erb et al., 2015 ; Gao et al., 2019 ; Iring et al., 2022 ; Reichenbach & Bringmann, 2016 ; Wallace et al., 2006 ), we hypothesised that they could also play a role in the altered functions of the aged cochlea. In this study, we used different mouse lines displaying varying degrees of progressive hearing loss to identify possible changes in the distribution and functional properties of P2Y receptors in the supporting cells of the ageing mouse.…”
Section: Introductionmentioning
confidence: 99%
“…The Ras homolog gene family protein A (RhoA)/Rho-associated coil-coil containing protein kinase (ROCK) pathway is involved in various physiological activities of cells, including cytoskeleton reconstruction, contraction, migration, phagocytic adhesion, stress ber formation, the in ammatory response, and angiogenesis, and recent studies have found it to be closely related to the polarization of microglia [23,24] . Targeting the inhibition of the RhoA/ROCK signaling pathway has gradually become the most promising direction for the treatment of TBI, and multiple molecules, such as Nogo, CSPG, and glutamate, may be upstream molecules of this pathway [25] .…”
Section: Discussionmentioning
confidence: 99%
“…P2RY12 expression decreases as microglia migrate and undergo a shift to an amoeboid state, increasing phagocytic and secretory activities [81]. In some neurodegenerative diseases, P2RY12 can be associated with activated, inflammatory microglia [81,82], but in the context of prion disease, both P2RY12 and TMEM119 are shown to decrease over the course of infection [30,34]. Changes in microglia are first detectable in the thalamus at preclinical stages, and cell morphology shifts from being ramified to activated or amoeboid.…”
Section: Dam! Look At All Those Microgliamentioning
confidence: 99%